Home
>
US Stocks
>
Nektar Therapeutics
Nektar Therapeutics
NKTR

Nektar Therapeutics

$16.4215.39%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
17.21
Today Low/High
16.41 / 17.21
52 Week Low/High
$13.4 / $26.75
P/E ratio
-5.2977
Market Cap
$2.51B

Company Details

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.
Organisation
Nektar Therapeutics
Headquaters
San Francisco, California, US
Employees
718
Industry
Health Technology
CEO
Howard Robin

Discover more

Frequently Asked Questions

What is Nektar Therapeutics share price today

Can Indians buy Nektar Therapeutics shares?

How can I buy Nektar Therapeutics shares from India?

Can Fractional shares of Nektar Therapeutics be purchased?

What are the documents required to start investing in Nektar Therapeutics stocks?

We are a SEBI registered investement advisor